Chondrosarcomas are malignant cartilaginous tumours that account for approximately 25% of all primary malignant bone tumours. They are most commonly found in older patients within the long bones, and can arise de novo or secondary from an existing benign cartilaginous neoplasm. On imaging these tumours have ring-and-arc chondroid matrix mineralisation with aggressive features such as lytic pattern, deep endosteal scalloping and soft-tissue extension.
Typical presentation is in the 4th and 5th decades and there is a slight male predominance of 1.5-2:1.
The histology of chondrosarcomas can differ according to their sub type (see below). In general these tumours are multilobulated (due to hyaline cartilage nodules) with central high water content and peripheral endochondral ossification. This accounts not only for the high T2 MRI signal (see below) but also for rings and arcs calcification or popcorn calcification.
Chondrosarcomas are divided into three (sometimes four) grades based primarily on cellularity (see: chondrosarcoma grading).
Chondrosarcomas are either primary, arising de novo, or secondary and arise from a pre-existent cartilaginous mass (see: secondary chondrosarcoma).
- conventional intramedullary chondrosarcoma (or central chondrosarcoma): low, intermediate or high grade (see: chondrosarcoma grading)
- juxtacortical chondrosarcoma: low, intermediate or high grade
- clear cell chondrosarcoma
- myxoid chondrosarcoma: usually intermediate grade
- mesenchymal chondrosarcoma: usually high grade
- extraskeletal chondrosarcoma
- dedifferentiated chondrosarcoma
Arising from pre-existing cartilagenous lesions:
- solitary osteochondroma
- hereditary multiple exostoses
- long bones: 45% (the reason is because the cartilage is more abundant in the long, tubular bones)
- pelvis: 25% especially around the triradiate cartilage
- ribs: 8%
- patients often younger than at other sites
- anterior ribs/costochondral junction
- spine: 7%
- greater male predominance 2-4:1
- thoracic most common
- posterior elements and vertebral body 45%
- posterior elements only 40%
- vertebral body only 15%
- scapula: 5%
- sternum: 2%
- head and neck (including cervical spine): 6-7%
- craniofacial: 2% (see chondrdosarcoma of the skull of base)
- hands and feet: rare c.f. enchondromas
Imaging findings vary somewhat with different sub types but do have some general features. Below are typical imaging appearances which are best demonstrated by conventional chondrosarcomas.
In general chondrosarcomas are large masses at the time of diagnosis, usually >4 cm in diameter and >10 cm in 50% of cases.
- lytic (50%)
- intralesional calcifications: ~70% (rings and arcs calcification or popcorn calcification)
- endosteal scalloping: affecting more than two thirds of the cortical thickness (c.f. less than two-thirds in enchondromas)
- moth eaten appearance or permeative appearance in higher grade tumours (see chondrosarcoma grading), e.g. myxoid, dedifferentiated and mesenchymal chondrosarcomas
- cortical remodelling, thickening and periosteal reaction are also useful in distinguishing between an enchondroma and low grade chondrosarcoma (see enchondroma vs. low grade chondrosarcoma)
The features seen on CT are the same as on plain film, but are simply better seen.
- 94% of cases demonstrate matrix calcificaiton, c.f. 60-78% on plain film.
- endosteal scalloping
- cortical breach, seen in ~90% of long bone chondrosarcoma, c.f. only ~10% of enchondromas
- soft tissue mass: density increases with increased grade of tumour do to increased cellularity
- heterogenous contrast enhancment
T1: low to intermediate signal
- iso- to slightly hyperintense cf. muscle
- iso- to slightly hypointense cf. grey matter (see chondrosarcoma of the base of skull)
- T2: very high intensity in nonmineralised/calcified portions
- gradient echo/SWI: blooming of mineralised/calcified portions
T1 C+ (Gd)
- most demonstrate heterogeneous moderate to intense contrast enhancement.
- enhancement can be septal and peripheral rim-like corresponding to fibrovascular septation between lobules of hyaline cartilage
Typically chondrosarcomas demonstrate increased uptake on bone scan, seen in over 80% of cases, and usually the uptake is quite intense. This is useful in helping to distinguish a low grade chondrosarcoma from an enchondroma as the latter has increased uptake in ~20% of cases, and usually to a lesser degree (see: enchondroma vs. low grade chondrosarcoma).
Treatment and prognosis
Prognosis varies with both grade and location. In general:
- grade 1: 90% 5-year survival
- grade 3: 29% 5-year survival
- long bones have a better prognosis than axial skeleton
The differential diagnosis for bone tumours is dependent on the age of the patient, with a very different set of differentials for the paediatric patient.
- bone-forming tumours
- chondromyxoid fibroma
- fibrous bone lesions
- bone marrow tumours
- other bone tumours or tumour-like lesions
- aneurysmal bone cyst
- benign fibrous histiocytoma
- giant cell tumour of bone
- Gorham massive osteolysis
- haemophilic pseudotumour
- intradiploic epidermoid cyst
- intraosseous lipoma
- cockade sign
- musculoskeletal angiosarcoma
- primary intraosseous haemangioma
- simple bone cyst
- impending fracture risk
- 1. Dähnert W. Radiology review manual. Lippincott Williams & Wilkins. (2003) ISBN:0781738954. Read it at Google Books - Find it at Amazon
- 2. Meyers SP, Hirsch WL, Curtin HD et-al. Chondrosarcomas of the skull base: MR imaging features. Radiology. 1992;184 (1): 103-8. Radiology (abstract) - Pubmed citation
- 3. Varma DG, Ayala AG, Carrasco CH et-al. Chondrosarcoma: MR imaging with pathologic correlation. Radiographics. 1992;12 (4): 687-704. Radiographics (abstract) - Pubmed citation
- 4. Murphey MD, Walker EA, Wilson AJ et-al. From the archives of the AFIP: imaging of primary chondrosarcoma: radiologic-pathologic correlation. Radiographics. 23 (5): 1245-78. doi:10.1148/rg.235035134 - Pubmed citation
- 5. Geirnaerdt MJ, Hogendoorn PC, Bloem JL et-al. Cartilaginous tumors: fast contrast-enhanced MR imaging. Radiology. 2000;214 (2): 539-46. Radiology (full text) - Pubmed citation